Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension

(2014) Gaël Deboeck et al.   PLoS One

Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension

(2013) Jason S. Fritz et al.   CHEST

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

(2013) Nazzareno Galiè et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Arterial Hypertension

(2013) Michael D. McGoon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Definitions and Diagnosis of Pulmonary Hypertension

(2013) Marius M. Hoeper et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Treatment Goals of Pulmonary Hypertension

(2013) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension

(2012) Stephen C. Mathai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

(2012) Nicole B. Gabler et al.   CIRCULATION

The 6-Minute Walk Test as a Primary Endpoint in Clinical Trials for Pulmonary Hypertension⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

(2012) Stuart Rich   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?

(2012) Gianluigi Savarese et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biomarkers and surrogate endpoints in clinical trials

(2012) Thomas R. Fleming et al.   STATISTICS IN MEDICINE

Systematic review of trials using vasodilators in pulmonary arterial hypertension: Why a new approach is needed

(2010) Alejandro Macchia et al.   AMERICAN HEART JOURNAL

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

(2009) N. Galie et al.   EUROPEAN HEART JOURNAL